However, it did enhance anti-tumor T-cell responses, increasing the presence of PD-1+ CD62Llow CD4+ and CD8+ T-cells and the production of PRF1, TNF-α, and IFN-γ. The gene discussed is PRF1; the disease is neoplasm.